U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery

• Publication date: July 2012
• Report size: 270 pages

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018. The market segments covered in this report include: - traditional blood glucose meters, - continuous glucose monitoring systems, - blood glucose test strips, - lancets and lancing devices, - insulin, - insulin syringes, - insulin pens and - insulin pumps Market growth is expecte...

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018.

The market segments covered in this report include:

- traditional blood glucose meters,
- continuous glucose monitoring systems,
- blood glucose test strips,
- lancets and lancing devices,
- insulin,
- insulin syringes,
- insulin pens and
- insulin pumps

Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Market growth for diabetes diagnosis, treatment and drug delivery will be led by double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments.

Within the diabetes diagnosis, treatment and drug deliver market, companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

In Vitro Diagnostic Industry in the United States

TABLE OF CONTENTS.I
LIST OF FIGURES.VI
LIST OF CHARTS.X
EXECUTIVE SUMMARY 1
1.1 U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET 1
1.2 GROWTH TRENDS BY SEGMENT .. 2
1.3 BLOOD GLUCOSE MONITORING MARKET .. 3
1.4 INSULIN MARKET. 4
1.5 INSULIN SYRINGE MARKET 5
1.6 INSULIN PEN MARKET .. 6
1.7 INSULIN PUMP MARKET .. 7
1.8 COMPETITIVE ANALYSIS . 8
RESEARCH METHODOLOGY.. 9
2.1 RESEARCH SCOPE 9
2.2 IDATA’S 9-STEP METHODOLOGY 9
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design . 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates . 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring.. 21
U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET
OVERVIEW 22
3.1 INTRODUCTION .. 22
3.1.1 Types of Diabetes.. 22
3.1.1.1 Type 1 Diabetes .22
3.1.1.2 Type 2 Diabetes .22
3.1.1.3 Gestational Diabetes ..23
3.1.1.4 Prediabetes ..23
3.1.2 Diabetes Complications. 24
3.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes . 26
3.1.4 Signs and Symptoms. 28
3.1.5 Diabetes Monitoring 29
3.1.5.1 Initial Diagnosis 29
3.1.5.2 Blood Glucose Monitoring Systems.30
3.1.5.3 Urinary Glucose Monitoring ..30
3.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices ..30
3.1.6 Treatment.. 32
3.1.6.1 Lifestyle Measures 32
3.1.6.2 Insulin .32
3.1.6.3 Oral Antidiabetic Drugs 32
3.1.6.4 Injectable Antidiabetic Drugs.33
3.1.7 Drug Delivery Systems 33
3.1.7.1 Insulin Syringes .33
3.1.7.2 Insulin Pens .33
3.1.7.3 Insulin Pumps .33
3.1.7.4 Inhaled Insulin34
3.2MARKET OVERVIEW 35
3.3 TREND ANALYSIS BY MARKET SEGMENT 40
3.4MARKET DRIVERS AND LIMITERS 43
3.4.1 Market Drivers 43
3.4.2 Market Limiters.. 44
3.5 COMPETITIVE ANALYSIS .. 46
3.5.1 Market Concentration. 54
3.6MERGERS AND ACQUISITIONS 56
TRADITIONAL BLOOD GLUCOSE METER MARKET.. 57
4.1 INTRODUCTION .. 57
4.2MARKET OVERVIEW 59
4.3MARKET ANALYSIS AND FORECAST .. 64
4.3.1 Professional Blood Glucose Meter Market.. 66
4.3.2 Personal Blood Glucose Meter Market . 72
4.4MARKET DRIVERS AND LIMITERS 75
4.4.1 Market Drivers 75
4.4.2 Market Limiters.. 76
4.5 COMPETITIVE ANALYSIS .. 78
CONTINUOUS GLUCOSE MONITORING MARKET 83
5.1 INTRODUCTION .. 83
5.2MARKET OVERVIEW 85
5.2.1 Total Continuous Glucose Monitoring Market.. 85
5.2.2 Emerging Markets: Intravascular Continuous Glucose Monitoring.. 85
5.3MARKET ANALYSIS AND FORECAST .. 90
5.3.1 Total CGM Market 90
5.4MARKET DRIVERS AND LIMITERS 97
5.4.1 Market Drivers 97
5.4.2 Market Limiters.. 98
5.5 COMPETITIVE ANALYSIS 100
BLOOD GLUCOSE TEST STRIP MARKET 103
6.1 INTRODUCTION 103
6.2MARKET OVERVIEW. 104
6.3MARKET ANALYSIS AND FORECAST 109
6.3.1 Professional Blood Glucose Test Strip Market 112
6.3.2 Personal Blood Glucose Test Strip Market .. 115
6.4MARKET DRIVERS AND LIMITERS . 118
6.4.1 Market Drivers. 118
6.4.2 Market Limiters 119
6.5 COMPETITIVE ANALYSIS 12
LANCET AND LANCING DEVICE MARKET 126
7.1 INTRODUCTION 126
7.2MARKET OVERVIEW. 127
7.3MARKET ANALYSIS AND FORECAST 132
7.3.1 Professional Lancet and Lancing Device Market.. 135
7.3.2 Personal Lancet and Lancing Device Market . 138
7.4MARKET DRIVERS AND LIMITERS . 141
7.4.1 Market Drivers. 141
7.4.2 Market Limiters 142
7.5 COMPETITIVE ANALYSIS 143
INSULIN MARKET. 147
8.1 INTRODUCTION 147
8.1.1 Insulin Types. 147
8.2MARKET OVERVIEW. 151
8.3MARKET ANALYSIS AND FORECAST 156
8.4MARKET DRIVERS AND LIMITERS . 166
8.4.1 Market Drivers. 166
8.4.2 Market Limiters 167
8.5 COMPETITIVE ANALYSIS 168
INSULIN SYRINGE MARKET .. 171
9.1 INTRODUCTION 171
9.2MARKET OVERVIEW. 172
9.3MARKET ANALYSIS AND FORECAST 176
9.3.1 Professional Insulin Syringe Market 179
9.3.2 Personal Insulin Syringe Market 182
9.4MARKET DRIVERS AND LIMITERS . 185
9.4.1 Market Drivers. 185
9.4.2 Market Limiters 186
9.5 COMPETITIVE ANALYSIS 187
INSULIN PEN MARKET. 190
10.1 INTRODUCTION . 190
10.2MARKET ANALYSIS AND FORECAST . 191
10.3MARKET DRIVERS AND LIMITERS .. 194
10.3.1 Market Drivers.. 194
10.3.2 Market Limiters. 195
10.4 COMPETITIVE ANALYSIS . 196
INSULIN PUMP MARKET 199
11.1 INTRODUCTION . 199
11.2MARKET OVERVIEW.. 201
11.3MARKET ANALYSIS AND FORECAST . 206
11.3.1 Total Traditional Insulin Pump Market 208
11.3.1.1 Traditional Pump Market 210
11.3.1.2 Infusion Set Market.213
11.3.2 Total Patch Pump Market 215
11.3.2.1 Patch Pump Controller Market 217
11.3.2.2 Insulin Pod Market .220
11.3.3 Simple Pump Market.. 223
11.4MARKET DRIVERS AND LIMITERS .. 226
11.4.1 Market Drivers.. 226
11.4.2 Market Limiters. 227
11.5 COMPETITIVE ANALYSIS . 229
11.5.1.1 Emerging Competitors..233
APPENDIX: EMERGING MARKETS & ALTERNATIVE THERAPIES. 234
12.1 ARTIFICIAL PANCREAS . 234
12.1.1 Mechanical Artificial Pancreas 234
12.1.2 Bio-Artificial Pancreas . 235
12.2 NEEDLELESS INJECTORS .. 236
ABBREVIATIONS 238